Elchonon M. Berkowitz

670 total citations
13 papers, 453 citations indexed

About

Elchonon M. Berkowitz is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Elchonon M. Berkowitz has authored 13 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Elchonon M. Berkowitz's work include Pneumonia and Respiratory Infections (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Herpesvirus Infections and Treatments (3 papers). Elchonon M. Berkowitz is often cited by papers focused on Pneumonia and Respiratory Infections (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Herpesvirus Infections and Treatments (3 papers). Elchonon M. Berkowitz collaborates with scholars based in United States, United Kingdom and Belgium. Elchonon M. Berkowitz's co-authors include Thomas C. Heineman, Mohamed El Idrissi, Brian Wynne, Thomas C. Shea, Genovefa A. Papanicolaou, M. J. Flynn, Edward A. Stadtmauer, Hannah M. Wexler, Keith M. Sullivan and Jo‐Anne H. Young and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Elchonon M. Berkowitz

12 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elchonon M. Berkowitz United States 8 293 80 65 63 60 13 453
Kihei Terada Japan 18 714 2.4× 64 0.8× 20 0.3× 72 1.1× 109 1.8× 57 995
Aleksandra Knežević Serbia 12 208 0.7× 12 0.1× 18 0.3× 16 0.3× 81 1.4× 47 464
Nahmias Aj United States 11 587 2.0× 39 0.5× 8 0.1× 25 0.4× 163 2.7× 19 721
Z. Smetana Israel 11 341 1.2× 68 0.8× 3 0.0× 47 0.7× 136 2.3× 25 535
Hideomi Asanuma Japan 11 494 1.7× 82 1.0× 5 0.1× 70 1.1× 141 2.4× 21 662
Susanne Hartwig France 9 396 1.4× 27 0.3× 20 0.3× 34 0.5× 74 1.2× 17 505
Grégory Catteau Belgium 12 766 2.6× 52 0.7× 15 0.2× 57 0.9× 66 1.1× 15 865
Y Pérol France 14 384 1.3× 54 0.7× 4 0.1× 16 0.3× 201 3.4× 87 756
Caroline S. de Brouwer Netherlands 18 435 1.5× 21 0.3× 10 0.2× 35 0.6× 299 5.0× 31 854
Tatsuru Yamanaka Japan 12 675 2.3× 34 0.4× 18 0.3× 3 0.0× 195 3.3× 37 963

Countries citing papers authored by Elchonon M. Berkowitz

Since Specialization
Citations

This map shows the geographic impact of Elchonon M. Berkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elchonon M. Berkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elchonon M. Berkowitz more than expected).

Fields of papers citing papers by Elchonon M. Berkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elchonon M. Berkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elchonon M. Berkowitz. The network helps show where Elchonon M. Berkowitz may publish in the future.

Co-authorship network of co-authors of Elchonon M. Berkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Elchonon M. Berkowitz. A scholar is included among the top collaborators of Elchonon M. Berkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elchonon M. Berkowitz. Elchonon M. Berkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Corte, Tamera J., Jürgen Behr, Vincent Cottin, et al.. (2024). Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(2). 230–238. 22 indexed citations
2.
Tenero, David M., Nicholas Farinola, Elchonon M. Berkowitz, et al.. (2018). Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers. Clinical Pharmacology in Drug Development. 8(6). 754–764. 16 indexed citations
3.
Berkowitz, Elchonon M., Graeme Moyle, Hans‐Jürgen Stellbrink, et al.. (2014). Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study. The Journal of Infectious Diseases. 211(8). 1279–1287. 144 indexed citations
4.
Stadtmauer, Edward A., Keith M. Sullivan, Francisco M. Marty, et al.. (2014). A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood. 124(19). 2921–2929. 112 indexed citations
5.
Stadtmauer, Edward A., Keith M. Sullivan, Francisco M. Marty, et al.. (2013). One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster Virus (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic Cell Transplant (HCT) Recipients. Biology of Blood and Marrow Transplantation. 19(2). S168–S169. 2 indexed citations
6.
Anon, Jack B., Elchonon M. Berkowitz, John Breton, & Monique Twynholm. (2006). Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis. American Journal of Otolaryngology. 27(4). 248–254. 5 indexed citations
7.
Anon, Jack B., Berrylin Ferguson, Monique Twynholm, et al.. (2006). Pharmacokinetically Enhanced Amoxicillin/Clavulanate (2,000/125 mg) in Acute Bacterial Rhinosinusitis caused by Streptococcus Pneumoniae, Including Penicillin-Resistant Strains. Ear Nose & Throat Journal. 85(8). 500–508. 2 indexed citations
8.
File, Thomas M., Javier Garau, Michael R. Jacobs, et al.. (2005). Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains. International Journal of Antimicrobial Agents. 25(2). 110–119. 15 indexed citations
10.
Finegold, S M, M. J. Flynn, Hannele Jousimies–Somer, et al.. (2002). Bacteriologic Findings Associated with Chronic Bacterial Maxillary Sinusitis in Adults. Clinical Infectious Diseases. 35(4). 428–433. 84 indexed citations
11.
Berkowitz, Elchonon M. & Beatriz G.T. Pogo. (1985). Molecular characterization of two strains of shope fibroma virus. Virology. 142(2). 437–440. 4 indexed citations
12.
Pogo, Beatriz G.T., et al.. (1984). Investigation of vaccinia virus DNA replication employing a conditional lethal mutant defective in DNA. Virology. 132(2). 436–444. 18 indexed citations
13.
Young, James F., Rebecca Elliott, Elchonon M. Berkowitz, & Peter Palese. (1980). MECHANISMS OF GENETIC VARIATION IN HUMAN INFLUENZA VIRUSES*. Annals of the New York Academy of Sciences. 354(1). 135–141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026